
Cellular and mitochondrial
SS-31
Lyophilized SS-31, unreconstituted. It is a mitochondria-targeted peptide discussed in experimental cellular research.
Also searched as: elamipretide, 2S
10 mg
€49.99
- Amount
- 10 mg, 50 mg
- Storage
- −20 °C · dry · dark
- COA
- Supplier certificate pending
About this material
SS-31 is supplied by Rierink Compounds as a laboratory research material. Made in Europe. It is a mitochondria-targeted peptide discussed in experimental cellular research. It sits with the compounds studied in laboratory research on cellular and mitochondrial pathways. The material is a lyophilized powder and is supplied unreconstituted. The companion reagent listed for it is BAC water. Store at −20 °C, dry and protected from light. For laboratory research use only. Not a medicine. Not for human or veterinary use. Rierink does not publish reconstitution volumes, dosing, or administration guidance.
Research context
SS-31. It is a mitochondria-targeted peptide discussed in experimental cellular research.
Published studies describe a research material and a study design. They are not a protocol for this vial, not a dose, and not a permission for human or veterinary use.
Recommended reagent
This is the laboratory reagent listed with this lyophilized material.
Certificates
These certificates come from our supplier and relate to the supplier's batches. They are not Rierink's own independent tests of the exact vial you receive. Every Rierink vial carries our own internal lot number, and independent testing of our own lots is underway; results will be published per lot. We welcome independent testing: any customer or lab is free to test our products, and we're happy to share results sent to us.
Supplier certificate pending
Research briefings
- Published Reports on TirzepatideIndexed preclinical and clinical papers describe tirzepatide as a dual GIP/GLP-1 receptor agonist studied for glycemic and weight-related readouts. Reports document substantial reductions in HbA1c (up to 2.6%) and body weight (15-21% in key
- Published Reports on TirzepatideIndexed preclinical and clinical papers describe tirzepatide as a dual GIP/GLP-1 receptor agonist studied for glycemic and weight-related readouts, distinct from the single-incretin, GHRH-analog, and mitochondrial-peptide literature already
- Published Reports on SS-31 (Elamipretide)Indexed cell, animal, and clinical papers describe SS-31 as a mitochondria-targeting tetrapeptide studied for cardiolipin interaction and organ-function readouts, and those records do not establish research-vial use.
Trustpilot
A small laboratory is built one honest sentence at a time.
We're new on Trustpilot and don't have any reviews yet. Be one of the first to share your experience.
We are still the company that picks up the phone. The next researcher finds us because someone wrote down what actually happened: the lot that matched the label, the parcel that arrived late, the reply that took a day too long. That public record is how a young lab earns a name.
Write the first review